tiprankstipranks
Trending News
More News >
Mizuho Medy Co., Ltd. (JP:4595)
:4595
Japanese Market

Mizuho Medy Co., Ltd. (4595) Price & Analysis

Compare
0 Followers

4595 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.17%98.84%
Insiders
0.17%
Mutual Funds
― Other Institutional Investors
98.84% Public Companies and
Individual Investors

4595 FAQ

What was Mizuho Medy Co., Ltd.’s price range in the past 12 months?
Mizuho Medy Co., Ltd. lowest stock price was ¥1341.00 and its highest was ¥1824.00 in the past 12 months.
    What is Mizuho Medy Co., Ltd.’s market cap?
    Mizuho Medy Co., Ltd.’s market cap is ¥29.20B.
      When is Mizuho Medy Co., Ltd.’s upcoming earnings report date?
      Mizuho Medy Co., Ltd.’s upcoming earnings report date is Aug 07, 2025 which is in 57 days.
        How were Mizuho Medy Co., Ltd.’s earnings last quarter?
        Mizuho Medy Co., Ltd. released its earnings results on May 09, 2025. The company reported ¥40.82 earnings per share for the quarter, beating the consensus estimate of N/A by ¥40.82.
          Is Mizuho Medy Co., Ltd. overvalued?
          According to Wall Street analysts Mizuho Medy Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Mizuho Medy Co., Ltd. pay dividends?
            Mizuho Medy Co., Ltd. pays a Annually dividend of ¥120 which represents an annual dividend yield of 6.52%. See more information on Mizuho Medy Co., Ltd. dividends here
              What is Mizuho Medy Co., Ltd.’s EPS estimate?
              Mizuho Medy Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Mizuho Medy Co., Ltd. have?
              Mizuho Medy Co., Ltd. has 19,051,200 shares outstanding.
                What happened to Mizuho Medy Co., Ltd.’s price movement after its last earnings report?
                Mizuho Medy Co., Ltd. reported an EPS of ¥40.82 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Mizuho Medy Co., Ltd.?
                  Currently, no hedge funds are holding shares in JP:4595

                  Company Description

                  Mizuho Medy Co., Ltd.

                  Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Fuji Pharma Co., Ltd.
                  Fuso Pharmaceutical Industries,Ltd.
                  KYORIN Pharmaceutical Co.,Ltd.
                  Daito Pharmaceutical Co., Ltd.
                  ASKA Pharmaceutical Holdings Co., Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis